Menu

Blog

Feb 6, 2024

Targeted Treatment for Rare GI Cancers May Extend Survival

Posted by in category: biotech/medical

In patients with biliary tract cancer with a BRAF mutation, treatment with dabrafenib plus trametinib shrank tumors, results from a phase 2 trial show.

Comments are closed.